Polen Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$688M |
| 2 |
Zoetis
ZTS
|
+$381M |
| 3 |
Nike
NKE
|
+$363M |
| 4 |
Abbott
ABT
|
+$304M |
| 5 |
Visa
V
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.27B |
| 2 |
ServiceNow
NOW
|
+$859M |
| 3 |
Adobe
ADBE
|
+$756M |
| 4 |
Amazon
AMZN
|
+$311M |
| 5 |
Netflix
NFLX
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.47% |
| 2 | Consumer Discretionary | 20.75% |
| 3 | Healthcare | 19.51% |
| 4 | Communication Services | 12.55% |
| 5 | Financials | 11.38% |
Similar funds
Polen Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Polen Capital Management held 111 positions worth $43.3B, up 4.4% from $41.5B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Polen Capital Management withdrew a net $1.86B in Q1 2024, closing 7 positions and reducing 62 holdings. Its most notable exit was Illumina, an estimated $81M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Polen Capital Management opened a new position in KB Financial Group worth $4.23M.
- Polen Capital Management's largest Q1 2024 buy was KB Financial Group: 81,167 shares worth $4.23M.
- Polen Capital Management added most to Thermo Fisher Scientific in Q1 2024, an estimated $688M increase.
- Polen Capital Management's biggest Q1 2024 reduction was PayPal, cutting an estimated $1.27B.
- Polen Capital Management fully exited Illumina in Q1 2024, selling an estimated $81M.
- Polen Capital Management's ten largest holdings make up 64% of its $43.3B portfolio in Q1 2024.
- Polen Capital Management opened 4 new positions and closed 7 in Q1 2024.
- Polen Capital Management's portfolio value rose 4.4% quarter-over-quarter to $43.3B.
Based on Polen Capital Management's 13F filing for Q1 2024, filed 10 May 2024.